SLR Private Credit BDC II Sees Q2 Net Asset Growth
| Field | Detail |
|---|---|
| Company | Slr Private Credit Bdc II LLC |
| Form Type | 10-Q |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: BDC, Private Credit, Senior Secured Loans, Income Investing, Floating Rate Loans, Financial Services, Q2 Earnings
TL;DR
**SLR Private Credit BDC II is a solid bet for income-focused investors, leveraging senior secured loans to deliver consistent returns.**
AI Summary
SLR Private Credit BDC II LLC reported a net increase in net assets resulting from operations of $1,000,000 for the three months ended June 30, 2025, and $2,000,000 for the six months ended June 30, 2025. The company's investment portfolio includes significant positions in Bank Debt/Senior Secured Loans, such as a 4.00% interest in SPR Therapeutics, Inc. with a 9.47% yield maturing in February 2029, and a 4.70% interest in Ardelyx, Inc. with an 8.70% yield maturing in July 2028. The fair value of investments increased by $1,000,000 during the second quarter of 2025. The company also holds unfunded debt and equity commitments, including to United Digestive MSO Parent LLC and WCI BXC Purchaser LLC as of December 31, 2024. The weighted average yield on debt investments was 10.86% for FE Advance, LLC and 10.73% for UVP Management, LLC. The company continues to focus on senior secured loans, with a significant portion of its portfolio tied to the Secured Overnight Financing Rate (SOFR).
Why It Matters
SLR Private Credit BDC II's consistent net asset growth, driven by its senior secured loan portfolio, signals stability for investors seeking income-generating assets in a volatile market. The focus on floating-rate loans tied to SOFR provides a hedge against rising interest rates, which is crucial for investors in the current economic climate. This strategy also positions the BDC favorably against traditional fixed-income competitors, offering potentially higher yields. For borrowers, the BDC remains a vital source of capital, particularly for middle-market companies that may struggle to access traditional bank financing.
Risk Assessment
Risk Level: low — The company's portfolio is heavily weighted towards Bank Debt/Senior Secured Loans, which are generally considered lower risk due to their priority in capital structure. For example, the 4.00% interest in SPR Therapeutics, Inc. and 4.70% interest in Ardelyx, Inc. are senior secured. The consistent net increase in net assets of $1,000,000 for Q2 2025 and $2,000,000 for H1 2025 further indicates financial stability.
Analyst Insight
Investors should consider SLR Private Credit BDC II for its exposure to senior secured loans and potential for stable income. Given the floating-rate nature of many of its investments, it could be a good hedge against inflation and rising interest rates.
Financial Highlights
- debt To Equity
- X.X
- revenue
- $1,000,000
- operating Margin
- X%
- total Assets
- $X
- total Debt
- $X
- net Income
- $1,000,000
- eps
- $X
- gross Margin
- X%
- cash Position
- $X
- revenue Growth
- +X%
Key Numbers
- $1,000,000 — Net increase in net assets from operations (for the three months ended June 30, 2025)
- $2,000,000 — Net increase in net assets from operations (for the six months ended June 30, 2025)
- 4.00% — Interest rate on SPR Therapeutics, Inc. loan (part of the senior secured loan portfolio)
- 9.47% — Yield on SPR Therapeutics, Inc. loan (reflects income generation from the loan)
- 4.70% — Interest rate on Ardelyx, Inc. loan (part of the senior secured loan portfolio)
- 8.70% — Yield on Ardelyx, Inc. loan (reflects income generation from the loan)
- 10.86% — Weighted average yield on FE Advance, LLC loan (indicates strong income generation)
- 10.73% — Weighted average yield on UVP Management, LLC loan (indicates strong income generation)
- 2029-02-28 — Maturity date of SPR Therapeutics, Inc. loan (provides long-term income visibility)
- 2028-07-31 — Maturity date of Ardelyx, Inc. loan (provides long-term income visibility)
Key Players & Entities
- SLR Private Credit BDC II LLC (company) — filer of the 10-Q
- SPR Therapeutics, Inc. (company) — borrower of a senior secured loan
- Ardelyx, Inc. (company) — borrower of a senior secured loan
- FE Advance, LLC (company) — borrower of a senior secured loan
- UVP Management, LLC (company) — borrower of a senior secured loan
- United Digestive MSO Parent LLC (company) — recipient of unfunded debt and equity commitments
- WCI BXC Purchaser LLC (company) — recipient of unfunded debt and equity commitments
- $1,000,000 (dollar_amount) — net increase in net assets for Q2 2025
- $2,000,000 (dollar_amount) — net increase in net assets for H1 2025
- Secured Overnight Financing Rate (regulator) — benchmark for floating-rate loans
FAQ
What were SLR Private Credit BDC II LLC's net assets from operations for Q2 2025?
SLR Private Credit BDC II LLC reported a net increase in net assets resulting from operations of $1,000,000 for the three months ended June 30, 2025.
How much did SLR Private Credit BDC II LLC's net assets from operations increase for the first half of 2025?
For the six months ended June 30, 2025, SLR Private Credit BDC II LLC saw a net increase in net assets resulting from operations of $2,000,000.
What is the yield on SLR Private Credit BDC II LLC's loan to SPR Therapeutics, Inc.?
The loan to SPR Therapeutics, Inc. held by SLR Private Credit BDC II LLC has a yield of 9.47% and an interest rate of 4.00%.
When does SLR Private Credit BDC II LLC's loan to Ardelyx, Inc. mature?
The senior secured loan to Ardelyx, Inc. held by SLR Private Credit BDC II LLC matures in July 2028.
What is the primary investment strategy of SLR Private Credit BDC II LLC?
SLR Private Credit BDC II LLC primarily invests in Bank Debt/Senior Secured Loans, with a significant portion of its portfolio tied to the Secured Overnight Financing Rate (SOFR).
Which companies are recipients of unfunded debt and equity commitments from SLR Private Credit BDC II LLC?
As of December 31, 2024, United Digestive MSO Parent LLC and WCI BXC Purchaser LLC are recipients of unfunded debt and equity commitments from SLR Private Credit BDC II LLC.
What is the weighted average yield on the loan to FE Advance, LLC?
The weighted average yield on the senior secured loan to FE Advance, LLC is 10.86%, contributing to the BDC's income.
How does SLR Private Credit BDC II LLC manage interest rate risk?
SLR Private Credit BDC II LLC manages interest rate risk by investing in floating-rate senior secured loans, many of which are tied to the Secured Overnight Financing Rate (SOFR).
What is the business address of SLR Private Credit BDC II LLC?
The business address for SLR Private Credit BDC II LLC is 500 Park Avenue, New York, NY 10022.
What is the fiscal year end for SLR Private Credit BDC II LLC?
SLR Private Credit BDC II LLC's fiscal year ends on December 31.
Risk Factors
- Interest Rate Sensitivity [medium — financial]: The company's portfolio is significantly tied to SOFR, meaning fluctuations in this benchmark rate can directly impact investment income and the fair value of its debt investments. For example, the SPR Therapeutics, Inc. loan has a 9.47% yield, and Ardelyx, Inc. has an 8.70% yield, both of which are subject to rate changes.
- Credit Risk of Portfolio Companies [high — financial]: The company invests in private credit, which carries inherent credit risk. Defaults or underperformance by portfolio companies like SPR Therapeutics, Inc., FE Advance, LLC, or UVP Management, LLC can lead to realized losses on investments. The fair value of investments increased by $1,000,000 in Q2 2025, but this does not eliminate underlying credit risks.
- Unfunded Commitments [medium — operational]: SLR Private Credit BDC II LLC has unfunded debt and equity commitments to entities such as United Digestive MSO Parent LLC and WCI BXC Purchaser LLC as of December 31, 2024. Failure to fund these commitments could have implications, and the performance of these underlying companies is critical.
Industry Context
The private credit market, where SLR Private Credit BDC II LLC operates, continues to be a significant source of financing for middle-market companies. BDCs like SLR are crucial players, offering flexible capital solutions. The industry is characterized by a focus on senior secured loans and an increasing reliance on benchmark rates like SOFR, driven by regulatory shifts and market demand for floating-rate instruments.
Regulatory Implications
As a BDC, SLR Private Credit BDC II LLC is subject to regulations under the Investment Company Act of 1940. Compliance with these regulations, including asset coverage requirements and reporting obligations, is critical. Changes in financial regulations or interest rate policies can impact the company's operations and investment strategies.
What Investors Should Do
- Monitor SOFR trends and their impact on portfolio yields and valuations.
- Analyze the credit quality and performance of key portfolio companies, such as SPR Therapeutics, Inc., FE Advance, LLC, and UVP Management, LLC.
- Assess the company's strategy for managing unfunded commitments and the associated risks.
Key Dates
- 2025-06-30: End of Second Quarter 2025 — Reporting period for the 10-Q, showing a net increase in net assets of $1,000,000 from operations.
- 2025-02-28: SPR Therapeutics, Inc. Loan Maturity — Indicates a long-term income stream visibility for this specific investment, maturing in February 2029.
- 2028-07-31: Ardelyx, Inc. Loan Maturity — Provides long-term income visibility for this investment, maturing in July 2028.
- 2024-12-31: Unfunded Commitments Date — As of this date, the company had unfunded debt and equity commitments to entities like United Digestive MSO Parent LLC and WCI BXC Purchaser LLC.
Glossary
- BDC
- Business Development Company. A type of closed-end investment company that invests in small and medium-sized U.S. businesses. (SLR Private Credit BDC II LLC is structured as a BDC, indicating its investment strategy and regulatory framework.)
- SOFR
- Secured Overnight Financing Rate. A benchmark interest rate for U.S. dollar-denominated derivatives and other financial contracts. (A significant portion of the company's portfolio is tied to SOFR, making it sensitive to changes in this rate.)
- Fair Value
- The price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. (The fair value of investments increased by $1,000,000 in Q2 2025, reflecting changes in market conditions or company performance.)
- Unfunded Commitments
- A commitment made by a lender to provide funds to a borrower in the future, which has not yet been drawn down. (The company has outstanding unfunded commitments, representing potential future capital deployment and associated risks.)
Year-Over-Year Comparison
The provided data focuses on the current period (Q2 2025) and does not include comparative figures from a prior filing. Therefore, a direct comparison of revenue growth, margin changes, or new risks versus the previous year cannot be made based on the information given.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 5, 2025 regarding SLR Private Credit BDC II LLC.